Taiwan detects first imported COVID-19 BA.3.2 case in 10yo Singaporean girl after arrival screening
A ten-year-old girl from Singapore has been confirmed as the first imported case of the COVID-19 BA.3.2 subvariant in Taiwan after being intercepted with a fever at Taoyuan International Airport.
- A Singaporean minor tested positive for the BA.3.2 subvariant upon arrival at Taiwan Taoyuan International Airport.
- The patient had not received a COVID-19 vaccination within the last 12 months and displayed a fever of 38.5 degrees Celsius.
- Taiwan health authorities have ruled out community transmission risk and maintain that the subvariant does not currently pose an increased threat of severe illness.
Taiwan has recorded its first imported case of the COVID-19 BA.3.2 subvariant after a ten-year-old girl arriving from Singapore tested positive.
The Centers for Disease Control (CDC) confirmed the detection following airport quarantine screenings, according to local media reports.
The child arrived in the country on 14 March 2026.
Upon entry at Taiwan Taoyuan International Airport, quarantine personnel intercepted her after she was found to have a fever of 38.5 degrees Celsius.
The girl agreed to provide a saliva sample for testing.
According to CDC Deputy Director-General Lin Ming-cheng (林明誠), subsequent laboratory analysis confirmed the presence of the BA.3.2 strain.
This marks the first appearance of the variant in Taiwan.
Epidemiological investigations revealed the patient had spent 14 days in Singapore immediately prior to her arrival.
Records indicate she had not received a COVID-19 vaccine in the 12 months leading up to her travel.
Following a Travel, Occupation, Contact, and Cluster (TOCC) assessment, quarantine officers issued a formal notice.
This instruction required the individual to seek professional medical attention within a 24-hour period.
The girl remained in Taiwan for several days, with her movements primarily focused within Taipei. She departed from Taiwan on 20 March 2026.
The CDC confirmed that no community transmission occurred during her stay.
The BA.3.2 strain was added to the World Health Organization (WHO) list of Variants Under Monitoring in December 2025.
Lin noted that while its global prevalence reached roughly four per cent, it has since plateaued.
Health officials stated there is no evidence suggesting the strain causes a significant increase in transmissibility.
Furthermore, there is no data indicating a higher risk of severe illness compared to previous Omicron subvariants.
Current medical consensus suggests that existing COVID-19 vaccines remain effective against severe complications from this variant. Lin emphasised that there is no immediate cause for public alarm regarding contact risks or community safety.
Despite the low risk to the general population, the CDC continues to advise high-risk groups to remain vigilant.
This includes individuals aged 65 and above and those with underlying chronic health conditions.
ROC Primary Care Association Secretary-General Lo Yuan-chang commented on regional health trends on 31 March 2026.
Lo noted that COVID-19 cases have been rising in certain nearby regions, including Okinawa.
The CDC clarified that while Japan's overall infection rates are declining, Okinawa has seen cases increase by 1.2 times over the past month.
The variant NB.1.8.1 remains the most prevalent strain in that region.
